May 8 (Reuters) - Johnson & Johnson:
* J&J says in march 2017, new jersey attorney general division of consumer affairs issued subpoena to janssen pharmaceuticals related to some practices in marketing opioids
* J&J says in march, ranking minority member of u.s. Senate committee on homeland security and governmental affairs issued request for information to jpi
* J&J - in April, got subpoena from u.s. Attorney for district of Massachusetts for documents relating to pharmaceutical copayment support programs for olysiotm, Simponi, Stelara
* J&J says in march 2017, Janssen Biotech Inc received civil investigative demand from U.S. DOJ Source text (bit.ly/2qTKCqQ) Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.